Caveolae and caveolin-1 in human term villous trophoblast

Placenta

Volumn 24, Issue 7, 2003, Pages 745-757

  Linton, Elizabeth A ^a   Rodriguez Linares, B ^a   Rashid Doubell, F ^a   Ferguson, D J P ^b   Redman, C W G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CAVEOLIN 1; MEMBRANE PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CAPILLARY ENDOTHELIUM; CAVEOLA; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOTROPHOBLAST; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PLACENTA VILLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; SYNCYTIUM; TROPHOBLAST; WESTERN BLOTTING;

EID: 0141503357     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(03)00106-1     Document Type: Article

References (55)

1. Anderson RG (1993) Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci U S A, 90, 10909-10913.
2. Brown DA & London E (1998) Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol, 14, 111-136.
3. Byrne S, Cheent A, Dimond J, Fisher G & Ockleford CD (2001) Immunocytochemical localization of a caveolin-1 isoform in human term extra-embryonic membranes using confocal laser scanning microscopy: implications for the complexity of the materno-fetal junction. Placenta, 22, 499-510.
4. Clover LM, Sargent IL, Townsend A, Tampe R & Redman CW (1995) Expression of TAP1 by human trophoblast. Eur J Immunol, 25, 543-553.
5. Conrad KP, Vill M, McGuire PG, Dail WG & Davis AK (1993) Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. FASEB J, 7, 1269-1276.
6. Couet J, Li S, Okamoto T, Ikezu T & Lisanti MP (1997) Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolac-associated proteins. J Biol Chem, 272, 6525-6533.
7. DiFederico E, Genbacev O & Fisher SJ (1999) Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol, 155, 293-301.
8. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H & Kurzchalia TV (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science, 293, 2449-2452.
9. Dye JF, Jablenska R, Donnelly JL, Lawrence L, Leach L, Clark P & Firth JA (2001) Phenotype of the endothelium in the human term placenta. Placenta, 22, 32-43.
10. Eis AL, Brockman DE, Pollock JS & Myatt L (1995) Immunohistochemical localization of endothelial nitric oxide synthase in human villous and extravillous trophoblast populations and expression during syncytiotrophoblast formation in vitro. Placenta, 16, 113-126.
11. Engelman JA, Zhang XL & Lisanti MP (1998) Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett, 436, 403-410.
12. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA & Michel T (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem, 271, 22810-22814.
13. Fra AM, Masserini M, Palestini P, Sonnino S & Simons K (1995) A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett, 375, 11-14.
14. Govers R, van der Sluijs P, van Donselaar E, Slot JW & Rabelink TJ (2002) Endothelial nitric oxide synthase and its negative regulator caveolin-1 localize to distinct perinuclear organelles. J Histochem Cytochem, 50, 779-788.
15. Griffoni C, Spisni E, Santi S, Riccio M, Guarnieri T & Tomasi V (2000) Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Biochem Biophys Res Cummun, 276, 756-761.
16. Haigh T, Chen C, Jones CJ & Aplin JD (1999) Studies of mesenchymal cells from 1st trimester human placenta: expression of cytokeratin outside the trophoblast lineage. Placenta, 20, 615-625.
17. Harlow E & Lane D (1988) Antibodies: A Laboratory Manual, pp. 423-470. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
18. Ikonen E (2001) Roles of lipid rafts in membrane transport, Curr Opin Cell Biol, 13, 470-477.
19. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T & Maruo T (2002) Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol, 186, 158-166.
20. Jaffe EA, Nachman RL, Becker CG & Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest, 52, 2745-2756.
21. Kliman HJ, Nestler JE, Sermasi E, Sanger JM & Strauss JF 3rd (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology, 118, 1567-1582.
22. Leung DN, Smith SC, To KF, Sahota DS & Baker PN (2001) Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol, 184, 1249-1250.
23. Li S, Song KS, Koh SS, Kikuchi A & Lisanti MP (1996) Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis. J Biol Chem, 271, 28647-28654.
24. Lisanti MP, Scherer PE, Tang ZL & Sargiacomo M (1994) Caveolae, caveolin and caveolin-rich membrane domains: a signaling hypothesis. Trends Cell Biol, 4, 231-235.
25. Luetterforst R, Stang E, Zorzi N, Carozzi A, Way M & Parton RG (1999) Molecular characterization of caveolin association with the Golgi complex: identification of a cis-Golgi targeting domain in the caveolin molecule. J Cell Biol, 145, 1443-1459.
26. Lyall F, Jablonka-Shariff A, Johnson RD, Olson LM & Nelson DM (1998) Gene expression of nitric oxide synthase in cultured human term placental trophoblast during in vitro differentiation. Placenta, 19, 253-260.
27. Lyden TW, Anderson CL & Robinson JM (2002) The endothelium but not the syncytiotrophoblast of human placenta expresses caveolae. Placenta, 23, 640-652.
28. Massimino ML, Griffoni C, Spisni E, Toni M & Tomasi V (2002) Involvement of caveolae and caveolae-like domains in signalling, cell survival and angiogenesis. Cell Signal, 14, 93-98.
29. Monier S, Dietzen DJ, Hastings WR, Lublin DM & Kurzchalia TV (1996) Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett, 388, 143-149.
30. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV & Simons K (1995) VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci U S A, 92, 10339-10343.
31. Myatt L, Brockman DE, Eis AL & Pollock JS (1993) Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta, 14, 487-495.
32. Oh P, McIntosh DP & Schnitzer JE (1998) Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol, 141, 101-114.
33. Peterson TE, Poppa V, Ueba H, Wu A, Yan C & Berk BC (1999) Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res, 85, 29-37.
34. Pelligrino DA, Ye S, Tan F, Santizo RA, Feinstein DL & Wang Q (2000) Nitric-oxide-dependent pial arteriolar dilation in the female rat: effects of chronic estrogen depletion and repletion. Biochem Biophys Res Commun, 269, 165-171.
35. Rashid-Doubell F, Redman CWG, Sargent IL & Linton EA (2002) Caveolin-1 expression in lipid rafts prepared from the BeWo, trophoblast cell line. Chem Phys Lipids, 118, 61.
36. Razani B, Schlegel A, Liu J & Lisanti MP (2001a) Caveolin-1, a putative tumour suppressor gene. Biochem Soc Trans, 29, 494-499.
37. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W & Lisanti MP (2001b) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem, 276, 38121-38138.
38. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR & Anderson RG (1992) Caveolin, a protein component of caveolae membrane coats. Cell, 68, 673-682.
39. Sacks GP, Clover L, Bainbridge D, Redman CWG & Sargent IL (2001) Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast. Placenta, 22, 550-559.
40. Sargiacomo M, Scherer PE, Tang Z, Kubler E, Song KS, Sanders MC & Lisanti MP (1995) Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci U S A, 92, 9407-9411.
41. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P & Lisanti MP (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem, 272, 29337-29346.
42. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC & Lodish HF (1994) Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol, 127, 1233-1243.
43. Schnitzer JE, Oh P, Pinney E & Allard J (1994) Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol, 127, 1217-1232.
44. Schnitzer JE, Oh P, Jacobson BS & Dvorak AM (1995) Caveolae from luminal plasmalemma of rat lung endothelium: microdomains enriched in caveolin, Ca(2+)-ATPase, and inositol trisphosphate receptor. Proc Natl Acad Sci U S A, 92, 1759-1763.
45. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RG & Michel T (1996) Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem, 271, 6518-6522.
46. Simons K & Ikonen E (1997) Functional rafts in cell membranes. Nature, 387, 569-572.
47. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T & Lisanti MP (1999) Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol, 19, 7289-7304.
48. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS & Lisanti MP (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem, 271, 15160-15165.
49. Sowa G, Pypaert M & Sessa WC (2001) Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci U S A, 98, 14072-14077.
50. Taggart MJ (2001) Smooth muscle excitation-contraction coupling: a role for caveolae and caveolins? News Physiol Sci, 16, 61-65.
51. Timme TL, Goltsov A, Tahir S, Li L, Wang J, Ren C, Johnston RN & Thompson TC (2000) Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene, 19, 3256-3265.
52. Turi A, Kiss AL & Mullner N (2001) Estrogen downregulates the number of caveolae and the level of caveolin in uterine smooth muscle. Cell Biol Int, 25, 785-794.
53. Volonte D, Galbiati F, Pestell RG & Lisanti MP (2001) Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr(14)) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J Biol Chem, 276, 8094-8103.
54. Zarlingo TJ, Eis AL, Brockman DE, Kossenjans W & Myatt L (1997) Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae. Placenta, 18, 511-520.
55. Zundel W, Swiersz LM & Giaccia A (2000) Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol Cell Biol, 20, 1507-1514.